Jaguar Health in red after ramp-up in 2022 Mytesi revenue misses estimates
Jaguar Health (NASDAQ:JAGX) shares fell -9% on Monday after the drug company missed revenue estimates despite a 176% year-over-year jump ...
Jaguar Health (NASDAQ:JAGX) shares fell -9% on Monday after the drug company missed revenue estimates despite a 176% year-over-year jump ...